Lantus Buyers Line Up As Plaintiffs In Recast Class Action
By Nadia Dreid ( January 5, 2023, 6:57 PM EST) -- Lantus insulin pen buyers are hopping on board the proposed class action-turned direct lawsuit as plaintiffs after counsel for the aggrieved medication buyers realized that the litigation accusing Sanofi-Aventis of anti-competitive behavior wasn't suited to class treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.